NCT07516093
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07516093
Title Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Nurix Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Central Georgia Cancer Care RECRUITING Macon Georgia 31210 United States Details
Fort Wayne Medical Oncology and Hematology RECRUITING Fort Wayne Indiana 46804 United States Details
Hematology Oncology of Indiana RECRUITING Indianapolis Indiana 46260 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology - West Texas RECRUITING Midland Texas 79124 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22201 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field